Nanotherapeutics Submits Investigational New Drug Application To FDA For Clinical Testing Of Oral Drug To Treat ...

Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the ...

Nanotherapeutics submits IND application with US FDA for clinical testing of oral drug to treat radiation exposure

Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid).

Dr. Walter Crinnion: Protecting the Health of Those in the Gulf

Heavy metal mercury is found naturally present in oil, as well as solvents from the oil. Both mercury and the solvents are potent toxins to the brain and nervous system

Social interaction reduces physical damage to brain by heart attack: Research

A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.

Nanotherapeutics Submits Investigational New Drug Application to FDA for Clinical Testing of Oral Drug to Treat ...

ALACHUA, Fla.----Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug Application with the Food and Drug Administration for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA .